4
Changes in Ownership
Mereo BioPharma Group plc Filed Acc 0000950170-24-078467
Chief Financial Officer sold 42,429 shares at an average $3.49 ($147,876)
From the SEC's structured data for this filing
Trades in this filing
Fox Christine Ann · Chief Financial Officer
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2024-06-25 | Sale : show line 1 in the form | −12,990 | $3.69 | $47,984 | 87,010 | D |
| 2024-06-26 | Sale : show line 2 in the form | −29,439 | $3.39 | $99,892 | 57,571 | D |
| Open-market sales · 42,429 sh · avg $3.49 · $147,876 | ||||||
Loading xslF345X05/ownership.xml…